Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “ ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on ...

The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) ("23andMe" or the "Company"), a leading human genetics company ...

Alternative investments are getting more focus from advisors over the last few years, and for good reason. They can offer ...

Ingevity Corporation NGVT recently announced plans to explore strategic alternatives for its Performance Chemicals Industrial ...

Me (ME) forms special board committee to explore strategic alternatives, including sale, restructuring, or business ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was sig ...

Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...